Page 936 - Textbook of Pathology, 6th Edition

920 type AB, 547 primary, 665-75 actinomycosis, 163-64
type B, 547 rapidly progressive, 667-69 examples of, 149-65
Gastroenteropathy, secondary, 675-78 leprosy, 157-61
haemorrhagic, 564-65 Glomerulosclerosis, sarcoidosis, 164-65
Gastrointestinal stromal tumour (GIST), 554-55 collapsing sclerosis, 674 skin, 774-75
Gastrointestinal tract, 538-91 diffuse, 677 syphilis, 161-63
Gaucher’s disease, 262-63 focal segmental, 673-74 prostate, 717
G-cell tumour, 829 nodular, 678 tuberculosis, 149-57
Genetic diseases, 256-63 Glomerulus, structure of, 650 uveitis, 508
Genetic disorders, 256-63 Glomus jugulare tumour, 515 Granulopoiesis, 345-47
Genome, human, 7 Glomus tumour (glomangioma), 412-13 Granulosa cell tumour,
Germ cell tumours, 193 Glossitis, 523 ovary, 748-49
ovary, 745-48 Glucose tolerance test (GTT), 827f testis, 713
testis, 709-13 Glucose 6-phosphate dehydrogenase (G6PD) Granulosa-theca cell tumour, 749
Ghon’s complex, 153-54 deficiency, 316-17 Graves’ disease, 806-07
GI bleeding, 591t Glucosuria, 826-27 Grawitz tumour, 694-96
Giant cell lesions of bone, 847-48 alimentary (lag storage), 827 Grossing, 10
Giant cell tumour of bone, 846-48 renal, 827 Ground glass nuclei, 813
Giant cell tumour of tendon sheath, 885 Glutathione-S-transferase (GST), 597 Growth factors, 210-11
Giant cells, 143-44 Gluten-sensitive enteropathy, 575 receptors for, 212
foreign body, 143 Glycocalyx, 21 Growth, adaptive disorder of, 53-59
Langhans’, 143 Glycogen stains, 12t, 40 Guillain-Barre syndrome, 892
Touton, 143 Glycogen storage diseases, 261-62 Gum hypertrophy, 363, 524
tumour, 143-44 Glycogenoses, 261t Gumma, 163f
Gibbs-Donnan equilibrium, 94 Glycolipids, 152 Gynaecomastia, 757
Giemsa, 12t, 277 Glycophorine, 289 Gynandroblastoma, 749
Gigantism, 793-94 Glycoproteins, adhesive, 170
Gilbert’s syndrome, 600 Glycosaminoglycans, 83, 170, 262
Gingivitis, 529 Glycosylated Hb (Hb A1C), 828 H
GIST (Gastrointestinal stromal tumour), 554-55 Goitre, 807-10
Gitter cells, 872 adenomatous, 808-10 5-Hydroxy tryptamine (HT), 136-37
Glanzman’s disease, 334 colloid, 807-08 H-substance, 339
Glaucoma, 510-11 diffuse toxic, 806-07 Haber-Weiss reaction, 136
Gleason’s staging, prostate, 720 endemic, 807 Haemangioblastoma, 414, 889
Glial fibrillary acidic protein (GFAP), 24 nodular, 808-10 Haemangioendothelioma, 413-14
Glioblastoma multiforme, 887-88 simple, 807-08 Haemangioma, 411-12
Gliomas, 886-90 sporadic, 807-08 capillary type, 411-12
Gliosis, 45, 881 Goitrogens, 807 cavernous type, 412
Glisson’s capsule, 592 Golgi apparatus, 24 granulation tissue type, 412
Global, hypoxic-ischaemic Gomori’s methenamine silver, 12t, 175, 176f liver, 633
encephalopathy, 879-80 Gonadoblastoma, mouth, 524
Globi, 158f ovary, 750 nose, 517
Glomerular basement membrane (GBM), 650, testis, 713 Haemangiopericytoma, 414
651f Goodpasture’s syndrome, 494, 667-68 Haematemesis,
INDEX
Glomerular diseases, 660-78 Gout and pseudogout, 853-55 of gastric origin, 554
classification of, 660t G-proteins, receptors, 26, 212 of oesophageal origin, 539-40
clinical manifestations of, 660-62 Grading of tumours, 204-05 Haematin, 42
contrasting features of, 676t Graft rejection, 65-66 Haematocele, 706f
definition of, 660 Graft versus host reaction, 66 Haematogenous spread of tumours, 201-02
pathogenesis of, 662-65 Graft, vascular, 460 Haematological neoplasms, 353-56
specific types of, 665-78 Gram Christian, 4 classification of, 353-54
Glomerular filtration rate (GFR), 653 Granular cell myoblastoma, 525, 869 etiology, 354-55
Glomerular injury, Granular cell tumour, posterior pathogenesis, 355-56
pathogenesis of, 662-65 pituitary, 796 Haematological values, 901t
Glomerulonephritis (GN), 665-75 Granulation tissue formation, 166-67 Haematoma, 107
acute, 665-67 Granulocytes, 141, 345 dissecting, 407-08
chronic, 674-75 Granuloma, 148-49 epidural, 882
crescentic, 667-69 annulare, 774 subdural, 882-83
distinguishing features of, 676t apical, 529 Haematopoiesis, 284-85
end stage, 674-75 eosinophilic, 385 extramedullary, 285, 360
focal, 672-74 caseating, 148-49 Haematopoietic stem cells, 285-86
IgA, 674 gravidarum, 412, 524 Haematoxylin bodies of Gross, 79, 444
mechanisms of, 662-65 inguinale, 178-79 Haematuria, 661-62, 691, 696
membranoproliferative, 671-72 lethal midline, 380, 403, 517 Haemochromatosis, 42, 627
membranous, 669-71 non-caseating, 164-85 Haemodialysis-associated amyloid, 86-87
minimal change disease (lipoid nephrosis), plasma cell, 384 Haemodynamic disturbances, 104-29
669 pyogenicum, 412, 524 Haemoglobin, 292
necrotising focal, 673 reparative, 816, 836 Haemoglobin disorders, 317-25
non-streptococcal, 667 sarcoid, 164-65 Haemoglobinopathies, 317-25
oedema in, 661 spermatic, 705-06 Haemoglobinopathy, unstable, 320
post-streptococcal, 665-67 Granulomatous inflammation, 150t Haemoglobinuria, 311